State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.

Ryan CE, Ahn IE, Sekar A, Rawstron A, Almeida J, Martin-Subero I, Parry EM, Alcoceba M, Calado DP, Orfao A, Langerak AW, Veelken H, Langerbeins P, Stephens DM, Parikh SA, Niemann CU, Roulland S, Stamatopoulos K, Slager SL, Shanafelt T, Ghia P, Okosun J, Davids MS

Open source

DOI: 10.1038/s41408-025-01341-6
Published: 2025 Aug 29
Container: Blood cancer journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-025-01341-6,
  title = {State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.},
  author = {Ryan CE and Ahn IE and Sekar A and Rawstron A and Almeida J and Martin-Subero I and Parry EM and Alcoceba M and Calado DP and Orfao A and Langerak AW and Veelken H and Langerbeins P and Stephens DM and Parikh SA and Niemann CU and Roulland S and Stamatopoulos K and Slager SL and Shanafelt T and Ghia P and Okosun J and Davids MS},
  year = {2025},
  journal = {Blood cancer journal},
  doi = {10.1038/s41408-025-01341-6},
  url = {https://doi.org/10.1038/s41408-025-01341-6}
}

RIS

TY  - JOUR
TI  - State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.
AU  - Ryan CE
AU  - Ahn IE
AU  - Sekar A
AU  - Rawstron A
AU  - Almeida J
AU  - Martin-Subero I
AU  - Parry EM
AU  - Alcoceba M
AU  - Calado DP
AU  - Orfao A
AU  - Langerak AW
AU  - Veelken H
AU  - Langerbeins P
AU  - Stephens DM
AU  - Parikh SA
AU  - Niemann CU
AU  - Roulland S
AU  - Stamatopoulos K
AU  - Slager SL
AU  - Shanafelt T
AU  - Ghia P
AU  - Okosun J
AU  - Davids MS
PY  - 2025
JO  - Blood cancer journal
DO  - 10.1038/s41408-025-01341-6
UR  - https://doi.org/10.1038/s41408-025-01341-6
ER  -

APA

CE, R., IE, A., A, S., A, R., J, A., I, M., EM, P., M, A., DP, C., A, O., AW, L., H, V., P, L., DM, S., SA, P., CU, N., S, R., K, S., SL, S., T, S., P, G., J, O., & MS, D. (2025). State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.. Blood cancer journal. https://doi.org/10.1038/s41408-025-01341-6

Source records

pubmed · retrieved 2026-09-25T17:31:22.035Z